Susan Nmn Ungar

Array ( [id] => 1593988 [patent_doc_number] => 06491914 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions including the anti-idiotypic monoclonal antibodies' [patent_app_type] => B1 [patent_app_number] => 09/448883 [patent_app_country] => US [patent_app_date] => 1999-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5039 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/491/06491914.pdf [firstpage_image] =>[orig_patent_app_number] => 09448883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1180262 [patent_doc_number] => 06737232 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-18 [patent_title] => 'IAPs associated cell cycle proteins, compositions and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/442013 [patent_app_country] => US [patent_app_date] => 1999-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 28201 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/737/06737232.pdf [firstpage_image] =>[orig_patent_app_number] => 09442013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1394897 [patent_doc_number] => 06531280 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => 'Method for identifying or isolating a molecule and molecules identified thereby' [patent_app_type] => B1 [patent_app_number] => 09/437858 [patent_app_country] => US [patent_app_date] => 1999-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7426 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531280.pdf [firstpage_image] =>[orig_patent_app_number] => 09437858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417809 [patent_doc_number] => 06506551 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia' [patent_app_type] => B1 [patent_app_number] => 09/415393 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8742 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506551.pdf [firstpage_image] =>[orig_patent_app_number] => 09415393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 888505 [patent_doc_number] => 07348412 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-03-25 [patent_title] => 'Ouabain-specific monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 09/412268 [patent_app_country] => US [patent_app_date] => 1999-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 10984 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/348/07348412.pdf [firstpage_image] =>[orig_patent_app_number] => 09412268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1290436 [patent_doc_number] => 06632934 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'MORC gene compositions and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/409604 [patent_app_country] => US [patent_app_date] => 1999-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 27 [patent_no_of_words] => 74224 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632934.pdf [firstpage_image] =>[orig_patent_app_number] => 09409604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 637357 [patent_doc_number] => 07125553 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-24 [patent_title] => 'Methods of inducing immune tolerance using immunotoxins' [patent_app_type] => utility [patent_app_number] => 09/383695 [patent_app_country] => US [patent_app_date] => 1999-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 25050 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125553.pdf [firstpage_image] =>[orig_patent_app_number] => 09383695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 637586 [patent_doc_number] => 07125659 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-24 [patent_title] => 'Method and screening candidate compounds for drug against tumor' [patent_app_type] => utility [patent_app_number] => 09/763175 [patent_app_country] => US [patent_app_date] => 1999-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5080 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125659.pdf [firstpage_image] =>[orig_patent_app_number] => 09763175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062947 [patent_doc_number] => 20020031531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'IMMUNOGENIC TLP COMPOSITION' [patent_app_type] => new [patent_app_number] => 09/284051 [patent_app_country] => US [patent_app_date] => 1999-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3635 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20020031531.pdf [firstpage_image] =>[orig_patent_app_number] => 09284051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411408 [patent_doc_number] => 06310184 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Anti-fibroblast growth factor-8 monoclonal antibody' [patent_app_type] => 1 [patent_app_number] => 9/326590 [patent_app_country] => US [patent_app_date] => 1999-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5168 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310184.pdf [firstpage_image] =>[orig_patent_app_number] => 326590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889073 [patent_doc_number] => 20020013285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'NUCLEOSOME-BASED ANTI-TUMOR COMPOSITIONS' [patent_app_type] => new [patent_app_number] => 09/323752 [patent_app_country] => US [patent_app_date] => 1999-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6310 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013285.pdf [firstpage_image] =>[orig_patent_app_number] => 09323752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059228 [patent_doc_number] => 06852318 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-08 [patent_title] => 'Methods for detecting and inhibiting angiogenesis' [patent_app_type] => utility [patent_app_number] => 09/307223 [patent_app_country] => US [patent_app_date] => 1999-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 14575 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852318.pdf [firstpage_image] =>[orig_patent_app_number] => 09307223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6377611 [patent_doc_number] => 20020119488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'EX-CORPORE METHOD FOR TREATING HUMAN BLOOD CELLS' [patent_app_type] => new [patent_app_number] => 09/297557 [patent_app_country] => US [patent_app_date] => 1999-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2684 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119488.pdf [firstpage_image] =>[orig_patent_app_number] => 09297557 [rel_patent_id] =>[rel_patent_doc_number] =>)